FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005954781> ?p ?o ?g. }

• W2005954781 endingPage "298" @default.
• W2005954781 startingPage "288" @default.
• W2005954781 abstract "Background/Aims: Obesity contributes to the development of cardiometabolic disorders such as type 2 diabetes, fatty liver disease and cardiovascular disease. Salvianolic acid B (Sal B) is a molecule derived from the root of Salvia miltiorrhiza (Danshen), which is a traditional Chinese medicine that is widely used to treat cardiovascular diseases. However, the role of Sal B in obesity and obesity-related metabolic disorders is unknown. In this study, we aimed to investigate the effects of Sal B on high-fat diet-induced obesity and determine the possible mechanisms involved. Methods: Male C57BL/6J mice fed a high-fat diet for 12 weeks received a supplement of Sal B (100 mg/kg/day) by gavage for a further 8 weeks. These mice were compared to control mice fed an un-supplemented high-fat diet. 3T3-L1 preadipocytes were used in vitro studies. Results: Sal B administration significantly decreased body weight, white adipose tissue weight, adipocyte size and lipid (triglyceride and total cholesterol) levels in obese mice. Eight weeks of Sal B administration also improved the intraperitoneal glucose tolerance test (IPGTT) and intraperitoneal insulin tolerance test (IPITT) scores in high-fat diet-induced obese mice. In 3T3-L1 preadipocytes that were cultured in vitro and induced to differentiate, Sal B reduced the accumulation of lipid droplets and lipid content in a dose-dependent manner. Immunoblotting indicated that Sal B decreased peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα) expression but increased the expression of GATA binding protein 2 and 3 (GATA 2, GATA 3) both in vivo and in vitro. Conclusion: Our data suggest that Sal B may reduce obesity and obesity-related metabolic disorders by suppressing adipogenesis. The effects of Sal B in adipose tissue may be related to its action on PPARγ, C/EBPα, GATA-2 and GATA-3." @default.
• W2005954781 created "2016-06-24" @default.
• W2005954781 creator A5002661071 @default.
• W2005954781 creator A5016888255 @default.
• W2005954781 creator A5021579165 @default.
• W2005954781 creator A5026970838 @default.
• W2005954781 creator A5044278113 @default.
• W2005954781 creator A5049059516 @default.
• W2005954781 creator A5065517749 @default.
• W2005954781 creator A5085189920 @default.
• W2005954781 creator A5085309861 @default.
• W2005954781 date "2014-01-01" @default.
• W2005954781 modified "2023-09-28" @default.
• W2005954781 title "Salvianolic Acid B Inhibited PPARγ Expression and Attenuated Weight Gain in Mice with High-Fat Diet-Induced Obesity" @default.
• W2005954781 cites W1547383812 @default.
• W2005954781 cites W1669533272 @default.
• W2005954781 cites W1972645543 @default.
• W2005954781 cites W1981922352 @default.
• W2005954781 cites W1982525833 @default.
• W2005954781 cites W1984064393 @default.
• W2005954781 cites W2008697716 @default.
• W2005954781 cites W2017097013 @default.
• W2005954781 cites W2028317042 @default.
• W2005954781 cites W2036760375 @default.
• W2005954781 cites W2042762933 @default.
• W2005954781 cites W2052563704 @default.
• W2005954781 cites W2052609811 @default.
• W2005954781 cites W2059920643 @default.
• W2005954781 cites W2065222114 @default.
• W2005954781 cites W2068688340 @default.
• W2005954781 cites W2090049353 @default.
• W2005954781 cites W2097636742 @default.
• W2005954781 cites W2102170193 @default.
• W2005954781 cites W2109421395 @default.
• W2005954781 cites W2121714067 @default.
• W2005954781 cites W2122778205 @default.
• W2005954781 cites W2127424952 @default.
• W2005954781 cites W2134984662 @default.
• W2005954781 cites W2136879851 @default.
• W2005954781 cites W2157248765 @default.
• W2005954781 cites W2161131489 @default.
• W2005954781 cites W2164529668 @default.
• W2005954781 cites W2173681478 @default.
• W2005954781 cites W2418856411 @default.
• W2005954781 cites W3272015 @default.
• W2005954781 doi "https://doi.org/10.1159/000362999" @default.
• W2005954781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25034045" @default.
• W2005954781 hasPublicationYear "2014" @default.
• W2005954781 type Work @default.
• W2005954781 sameAs 2005954781 @default.
• W2005954781 citedByCount "49" @default.
• W2005954781 countsByYear W20059547812015 @default.
• W2005954781 countsByYear W20059547812016 @default.
• W2005954781 countsByYear W20059547812017 @default.
• W2005954781 countsByYear W20059547812018 @default.
• W2005954781 countsByYear W20059547812019 @default.
• W2005954781 countsByYear W20059547812020 @default.
• W2005954781 countsByYear W20059547812021 @default.
• W2005954781 countsByYear W20059547812022 @default.
• W2005954781 crossrefType "journal-article" @default.
• W2005954781 hasAuthorship W2005954781A5002661071 @default.
• W2005954781 hasAuthorship W2005954781A5016888255 @default.
• W2005954781 hasAuthorship W2005954781A5021579165 @default.
• W2005954781 hasAuthorship W2005954781A5026970838 @default.
• W2005954781 hasAuthorship W2005954781A5044278113 @default.
• W2005954781 hasAuthorship W2005954781A5049059516 @default.
• W2005954781 hasAuthorship W2005954781A5065517749 @default.
• W2005954781 hasAuthorship W2005954781A5085189920 @default.
• W2005954781 hasAuthorship W2005954781A5085309861 @default.
• W2005954781 hasBestOaLocation W20059547811 @default.
• W2005954781 hasConcept C126322002 @default.
• W2005954781 hasConcept C134018914 @default.
• W2005954781 hasConcept C142724271 @default.
• W2005954781 hasConcept C151955695 @default.
• W2005954781 hasConcept C170493617 @default.
• W2005954781 hasConcept C171089720 @default.
• W2005954781 hasConcept C187345961 @default.
• W2005954781 hasConcept C188947578 @default.
• W2005954781 hasConcept C204787440 @default.
• W2005954781 hasConcept C2776175234 @default.
• W2005954781 hasConcept C2776332195 @default.
• W2005954781 hasConcept C2778163477 @default.
• W2005954781 hasConcept C2778913445 @default.
• W2005954781 hasConcept C511355011 @default.
• W2005954781 hasConcept C71924100 @default.
• W2005954781 hasConceptScore W2005954781C126322002 @default.
• W2005954781 hasConceptScore W2005954781C134018914 @default.
• W2005954781 hasConceptScore W2005954781C142724271 @default.
• W2005954781 hasConceptScore W2005954781C151955695 @default.
• W2005954781 hasConceptScore W2005954781C170493617 @default.
• W2005954781 hasConceptScore W2005954781C171089720 @default.
• W2005954781 hasConceptScore W2005954781C187345961 @default.
• W2005954781 hasConceptScore W2005954781C188947578 @default.
• W2005954781 hasConceptScore W2005954781C204787440 @default.
• W2005954781 hasConceptScore W2005954781C2776175234 @default.
• W2005954781 hasConceptScore W2005954781C2776332195 @default.
• W2005954781 hasConceptScore W2005954781C2778163477 @default.
• W2005954781 hasConceptScore W2005954781C2778913445 @default.

• next